PharmAust Receives $546K R&D Rebate from ATO
160201_PharmAust Receives $546K R&D Rebate from ATO
160201_PharmAust Receives $546K R&D Rebate from ATO
160129_Appendix 4C – Quarterly Report & Company Update
160118_USA Roadshow Presentation – January 2016
160111_Juniper Pharma Services to reformulate MPL for Phase II
160104_PharmAust Featured on RedChip Money Report on Bloomberg
151221_Epichem Awarded Two Year Contract Extension from DNDi
161213_Change of Director’s Interest Notice
151126_GenScript Further Pre-Clinical Validation for Phase II Trial
151124_RedChip appointed to begin Global Investor Relations Program